Concepedia

M. Tsuboi

MT

1

Publications

15

Citations

1

H-Index

2022

Active since

Affiliations

University of Kansas Medical Center(Current)

M. Tsuboi is an author at University of Kansas Medical Center specializing in immunology, neoadjuvant therapy, and medicine.

Top concepts

Publications per year

2022–2022

1

Publications

1

LBA4 CANOPY-N: A phase II study of canakinumab (CAN) or pembrolizumab (PEM), alone or in combination, as neoadjuvant therapy in patients (pts) with resectable stage Ib–IIIa non-small cell lung cancer (NSCLC)

Tony Mok, J.L. Pujol, M. Tsuboi et al. · Annals of Oncology · 2022 · 15 citations

, , +8

Rows per page

1–1 of 1